Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 421 AL 435

Antioxidant approaches for the treatment of Alzheimer's disease

Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G.

Expert Rev Neurother. 2010 Jul;10(7):1201-8. doi: 10.1586/ern.10.74.

Autophagy in Alzheimer's disease

Moreira PI, Santos RX, Zhu X, Lee HG, Smith MA, Casadesus G, Perry G.

Expert Rev Neurother. 2010 Jul;10(7):1209-18. doi: 10.1586/ern.10.84.

An amyloid-notch hypothesis for Alzheimer's disease

Ethell DW.

Neuroscientist. 2010 Dec;16(6):614-7. doi: 10.1177/1073858410366162. Epub 2010 Jun 30.

[Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands]

Wouters CJ, Dautzenberg L, Thissen A, Dautzenberg PL.

Tijdschr Gerontol Geriatr. 2010 Jun;41(3):146-50. doi: 10.1007/BF03096196.

Psychometric characteristics of the Rivermead Behavioural Memory Test (RBMT) as an early detection instrument for dementia and mild cognitive impairment in Brazil

Yassuda MS, Flaks MK, Viola LF, Pereira FS, Memória CM, Nunes PV, Forlenza OV.

Int Psychogeriatr. 2010 Sep;22(6):1003-11. doi: 10.1017/S1041610210001055. Epub 2010 Jul 2.

Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains

Lin CJ, Huang HC, Jiang ZF.

Brain Res Bull. 2010 Jul 30;82(5-6):235-42. doi: 10.1016/j.brainresbull.2010.06.003. Epub 2010 Jun 17.

Determination of cerebrospinal fluid cystatin C on Architect ci8200

Ndjole AM, Bodolea C, Nilsen T, Gordh T, Flodin M, Larsson A.

J Immunol Methods. 2010 Aug 31;360(1-2):84-8. doi: 10.1016/j.jim.2010.06.012. Epub 2010 Jun 21.

Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels

Timmer NM, van Dijk L, van der Zee CE, Kiliaan A, de Waal RM, Verbeek MM.

Neurobiol Dis. 2010 Oct;40(1):340-7. doi: 10.1016/j.nbd.2010.06.008. Epub 2010 Jun 22.

Vitamin D and Alzheimer's disease: is there a link?

Pogge E.

Consult Pharm. 2010 Jul;25(7):440-50. doi: 10.4140/TCP.n.2010.440.

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S.

Arch Gen Psychiatry. 2010 Jul;67(7):739-48. doi: 10.1001/archgenpsychiatry.2010.78.

Temporal course of depressive symptoms during the development of Alzheimer disease

Wilson RS, Hoganson GM, Rajan KB, Barnes LL, Mendes de Leon CF, Evans DA.

Neurology. 2010 Jul 6;75(1):21-6. doi: 10.1212/WNL.0b013e3181e620c5.

Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept

Roe CM, Mintun MA, Ghoshal N, Williams MM, Grant EA, Marcus DS, Morris JC.

Neurology. 2010 Jul 6;75(1):42-8. doi: 10.1212/WNL.0b013e3181e620f4.

Vascular pathology in Alzheimer's disease

Miyakawa T.

Psychogeriatrics. 2010 Mar;10(1):39-44. doi: 10.1111/j.1479-8301.2009.00294.x.

Alzheimer's disease: clinical trials and drug development

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M.

Lancet Neurol. 2010 Jul;9(7):702-16. doi: 10.1016/S1474-4422(10)70119-8.

Learning from failure

Nat Rev Drug Discov. 2010 Jul;9(7):499. doi: 10.1038/nrd3222.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias